estimated revenue glp-1 drugs Analysts Forecast Lofty Revenues for Treating Type 2 Diabetes and Obesity McKee's proposed FY2027 budget drops
Description
While insurers receive rebates to offset some of their costs, the list prices of GLP-1 drugs are about $1,000 per month, and growing demand for these medications could put upward pressure on premiums
Cell Metab 26(5):709718 e703
Both tiers below are negotiated for our readers and not available on Embodys standard offering
Availability also varies by state
Diabetes Care 40, 821831
But if Bain is now making an economic argument, now that would be bold, no
